Your browser doesn't support javascript.
loading
Haploinsufficiency of the Sin3/HDAC corepressor complex member SIN3B causes a syndromic intellectual disability/autism spectrum disorder.
Latypova, Xenia; Vincent, Marie; Mollé, Alice; Adebambo, Oluwadamilare A; Fourgeux, Cynthia; Khan, Tahir N; Caro, Alfonso; Rosello, Monica; Orellana, Carmen; Niyazov, Dmitriy; Lederer, Damien; Deprez, Marie; Capri, Yline; Kannu, Peter; Tabet, Anne Claude; Levy, Jonathan; Aten, Emmelien; den Hollander, Nicolette; Splitt, Miranda; Walia, Jagdeep; Immken, Ladonna L; Stankiewicz, Pawel; McWalter, Kirsty; Suchy, Sharon; Louie, Raymond J; Bell, Shannon; Stevenson, Roger E; Rousseau, Justine; Willem, Catherine; Retiere, Christelle; Yang, Xiang-Jiao; Campeau, Philippe M; Martinez, Francisco; Rosenfeld, Jill A; Le Caignec, Cédric; Küry, Sébastien; Mercier, Sandra; Moradkhani, Kamran; Conrad, Solène; Besnard, Thomas; Cogné, Benjamin; Katsanis, Nicholas; Bézieau, Stéphane; Poschmann, Jeremie; Davis, Erica E; Isidor, Bertrand.
Afiliación
  • Latypova X; Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; Center for Human Disease Modeling, Duke University Medical Center, Durham, NC 27701, USA; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.
  • Vincent M; Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.
  • Mollé A; Université de Nantes, CHU Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, ITUN, 44000 Nantes, France.
  • Adebambo OA; Center for Human Disease Modeling, Duke University Medical Center, Durham, NC 27701, USA.
  • Fourgeux C; Université de Nantes, CHU Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, ITUN, 44000 Nantes, France.
  • Khan TN; Center for Human Disease Modeling, Duke University Medical Center, Durham, NC 27701, USA; Department of Biological Sciences, National University of Medical Sciences, 46000 Rawalpindi, Pakistan.
  • Caro A; Unidad de Genética, Grupo de Investigación Traslacional en Genética, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
  • Rosello M; Unidad de Genética, Grupo de Investigación Traslacional en Genética, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
  • Orellana C; Unidad de Genética, Grupo de Investigación Traslacional en Genética, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
  • Niyazov D; Department of Pediatrics, Ochsner Clinic, New Orleans, LA 70128, USA.
  • Lederer D; Centre de Génétique Humaine, IPG, 6041 Gosselies, Belgium.
  • Deprez M; Service de Neuropédiatrie, Clinique Saint Elizabeth, 5000 Namur, Belgium.
  • Capri Y; Service de Génétique Médicale, Hôpital Robert Debré, 75019 Paris, France.
  • Kannu P; Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
  • Tabet AC; Service de Cytogénétique, Hôpital Robert Debré, 75019 Paris, France.
  • Levy J; Service de Cytogénétique, Hôpital Robert Debré, 75019 Paris, France.
  • Aten E; Department of Clinical Genetics, Leiden University Medical Center, 2333 Leiden, the Netherlands.
  • den Hollander N; Department of Clinical Genetics, Leiden University Medical Center, 2333 Leiden, the Netherlands.
  • Splitt M; Northern Genetics Service, Institute of Genetic Medicine, Newcastle Upon Tyne NE1 3BZ, UK.
  • Walia J; Kingston General Hospital Research Institute, 76 Stuart Street, Kingston, ON K7L 2V7, Canada.
  • Immken LL; Clinical Genetics, Dell Children's Medical Group, Austin, TX 78731, USA.
  • Stankiewicz P; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
  • McWalter K; GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.
  • Suchy S; GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.
  • Louie RJ; Greenwood Genetic Center, 106 Gregor Mendel Cir, Greenwood, SC 29646, USA.
  • Bell S; Greenwood Genetic Center, 106 Gregor Mendel Cir, Greenwood, SC 29646, USA.
  • Stevenson RE; Greenwood Genetic Center, 106 Gregor Mendel Cir, Greenwood, SC 29646, USA.
  • Rousseau J; Sainte-Justine Hospital, 3175, Cote-Sainte-Catherine, Montreal, QC, Canada.
  • Willem C; Etablissement Français du Sang, 44000 Nantes, France.
  • Retiere C; Etablissement Français du Sang, 44000 Nantes, France; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44000 Nantes, France; LabEx IGO, Nantes 44000, France.
  • Yang XJ; Rosalind & Morris Goodman Cancer Research Center and Department of Medicine, McGill University, Montreal, QC H3A 1A3, Canada.
  • Campeau PM; Sainte-Justine Hospital, 3175, Cote-Sainte-Catherine, Montreal, QC, Canada.
  • Martinez F; Unidad de Genética, Grupo de Investigación Traslacional en Genética, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
  • Rosenfeld JA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Le Caignec C; Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.
  • Küry S; Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.
  • Mercier S; Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.
  • Moradkhani K; Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.
  • Conrad S; Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France.
  • Besnard T; Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.
  • Cogné B; Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.
  • Katsanis N; Center for Human Disease Modeling, Duke University Medical Center, Durham, NC 27701, USA; Advanced Center for Translational and Genetic Medicine, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA; Department of Pediatrics, F
  • Bézieau S; Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France.
  • Poschmann J; Université de Nantes, CHU Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie, UMR 1064, ITUN, 44000 Nantes, France. Electronic address: jeremie.poschmann@univ-nantes.fr.
  • Davis EE; Advanced Center for Translational and Genetic Medicine, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic ad
  • Isidor B; Service de Génétique Médicale, CHU Nantes, 9 quai Moncousu, 44093 Nantes Cedex 1, France; L'Institut du Thorax, INSERM, CNRS, Université de Nantes, 44007 Nantes, France. Electronic address: bertrand.isidor@chu-nantes.fr.
Am J Hum Genet ; 108(5): 929-941, 2021 05 06.
Article en En | MEDLINE | ID: mdl-33811806
ABSTRACT
Proteins involved in transcriptional regulation harbor a demonstrated enrichment of mutations in neurodevelopmental disorders. The Sin3 (Swi-independent 3)/histone deacetylase (HDAC) complex plays a central role in histone deacetylation and transcriptional repression. Among the two vertebrate paralogs encoding the Sin3 complex, SIN3A variants cause syndromic intellectual disability, but the clinical consequences of SIN3B haploinsufficiency in humans are uncharacterized. Here, we describe a syndrome hallmarked by intellectual disability, developmental delay, and dysmorphic facial features with variably penetrant autism spectrum disorder, congenital malformations, corpus callosum defects, and impaired growth caused by disruptive SIN3B variants. Using chromosomal microarray or exome sequencing, and through international data sharing efforts, we identified nine individuals with heterozygous SIN3B deletion or single-nucleotide variants. Five individuals harbor heterozygous deletions encompassing SIN3B that reside within a ∼230 kb minimal region of overlap on 19p13.11, two individuals have a rare nonsynonymous substitution, and two individuals have a single-nucleotide deletion that results in a frameshift and predicted premature termination codon. To test the relevance of SIN3B impairment to measurable aspects of the human phenotype, we disrupted the orthologous zebrafish locus by genome editing and transient suppression. The mutant and morphant larvae display altered craniofacial patterning, commissural axon defects, and reduced body length supportive of an essential role for Sin3 function in growth and patterning of anterior structures. To investigate further the molecular consequences of SIN3B variants, we quantified genome-wide enhancer and promoter activity states by using H3K27ac ChIP-seq. We show that, similar to SIN3A mutations, SIN3B disruption causes hyperacetylation of a subset of enhancers and promoters in peripheral blood mononuclear cells. Together, these data demonstrate that SIN3B haploinsufficiency leads to a hitherto unknown intellectual disability/autism syndrome, uncover a crucial role of SIN3B in the central nervous system, and define the epigenetic landscape associated with Sin3 complex impairment.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteínas Represoras / Haploinsuficiencia / Trastorno del Espectro Autista / Histona Desacetilasas / Discapacidad Intelectual Tipo de estudio: Etiology_studies / Prognostic_studies Idioma: En Revista: Am J Hum Genet Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteínas Represoras / Haploinsuficiencia / Trastorno del Espectro Autista / Histona Desacetilasas / Discapacidad Intelectual Tipo de estudio: Etiology_studies / Prognostic_studies Idioma: En Revista: Am J Hum Genet Año: 2021 Tipo del documento: Article